4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-22-027077
CEO sold 50,000 shares at an average $65.76 ($3,288,081)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Evans John M. CEO | 2022-07-28 | Sale | −10,181 | $64.87 | $660,429 | 1,108,339 | D |
| Evans John M. CEO | 2022-07-28 | Sale | −15,236 | $65.82 | $1,002,896 | 1,093,103 | D |
| Evans John M. CEO | 2022-07-28 | Sale | −1,562 | $66.74 | $104,255 | 1,091,541 | D |
| Evans John M. CEO | 2022-07-28 | Sale | −2,848 | $67.80 | $193,093 | 1,088,693 | D |
| Evans John M. CEO | 2022-07-28 | Sale | −173 | $68.49 | $11,849 | 1,088,520 | D |
| Evans John M. CEO | 2022-07-28 | Sale | −6,953 | $64.88 | $451,113 | 136,047 | I |
| Evans John M. CEO | 2022-07-28 | Sale | −10,599 | $65.92 | $698,673 | 125,448 | I |
| Evans John M. CEO | 2022-07-28 | Sale | −201 | $66.61 | $13,389 | 125,247 | I |
| Evans John M. CEO | 2022-07-28 | Sale | −2,247 | $67.82 | $152,383 | 123,000 | I |
| Open-market sales · 50,000 sh · avg $65.76 · $3,288,081 | |||||||
Loading xslF345X03/doc4.xml…